Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0004300 Exon-Exon chr12:120576127-120587524 chr12:120138323-120149720 1818 nt 0.5677
hsa_GCN1L1_0004400 Exon-Exon chr12:120576127-120591211 chr12:120138323-120153407 2382 nt 0.5714
hsa_GCN1L1_0004500 Exon-Exon chr12:120576127-120598059 chr12:120138323-120160255 250 nt 0.4400
hsa_GCN1L1_0004600 Exon-Exon chr12:120576127-120602525 chr12:120138323-120164721 250 nt 0.4320
hsa_GCN1L1_0004700 Exon-Exon chr12:120576127-120615358 chr12:120138323-120177555 250 nt 0.4160
hsa_GCN1L1_0004800 Exon-Exon chr12:120576127-120616562 chr12:120138323-120178759 250 nt 0.4480
hsa_GCN1L1_0004900 Exon-Exon chr12:120576499-120585076 chr12:120138695-120147272 1430 nt 0.5664
hsa_GCN1L1_0005000 Exon-Exon chr12:120576499-120602525 chr12:120138695-120164721 250 nt 0.4400
hsa_GCN1L1_0005100 Exon-Exon chr12:120576499-120611973 chr12:120138695-120174169 250 nt 0.4480
hsa_GCN1L1_0005200 Exon-Exon chr12:120576499-120615358 chr12:120138695-120177555 250 nt 0.4240
Showing 31 to 40 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].